Cargando…
Optimisation of the Synthesis and Cell Labelling Conditions for [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
BACKGROUND: There is a need to better characterise cell-based therapies in preclinical models to help facilitate their translation to humans. Long-term high-resolution tracking of the cells in vivo is often impossible due to unreliable methods. Radiolabelling of cells has the advantage of being able...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578071/ https://www.ncbi.nlm.nih.gov/pubmed/34231103 http://dx.doi.org/10.1007/s11307-021-01622-z |
_version_ | 1784596198056787968 |
---|---|
author | Friberger, Ida Jussing, Emma Han, Jinming Goos, Jeroen A. C. M. Siikanen, Jonathan Kaipe, Helen Lambert, Mélanie Harris, Robert A. Samén, Erik Carlsten, Mattias Holmin, Staffan Tran, Thuy A. |
author_facet | Friberger, Ida Jussing, Emma Han, Jinming Goos, Jeroen A. C. M. Siikanen, Jonathan Kaipe, Helen Lambert, Mélanie Harris, Robert A. Samén, Erik Carlsten, Mattias Holmin, Staffan Tran, Thuy A. |
author_sort | Friberger, Ida |
collection | PubMed |
description | BACKGROUND: There is a need to better characterise cell-based therapies in preclinical models to help facilitate their translation to humans. Long-term high-resolution tracking of the cells in vivo is often impossible due to unreliable methods. Radiolabelling of cells has the advantage of being able to reveal cellular kinetics in vivo over time. This study aimed to optimise the synthesis of the radiotracers [(89)Zr]Zr-oxine (8-hydroxyquinoline) and [(89)Zr]Zr-DFO-NCS (p-SCN-Bn-Deferoxamine) and to perform a direct comparison of the cell labelling efficiency using these radiotracers. PROCEDURES: Several parameters, such as buffers, pH, labelling time and temperature, were investigated to optimise the synthesis of [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS in order to reach a radiochemical conversion (RCC) of >95 % without purification. Radio-instant thin-layer chromatography (iTLC) and radio high-performance liquid chromatography (radio-HPLC) were used to determine the RCC. Cells were labelled with [(89)Zr]Zr-oxine or [(89)Zr]Zr-DFO-NCS. The cellular retention of (89)Zr and the labelling impact was determined by analysing the cellular functions, such as viability, proliferation, phagocytotic ability and phenotypic immunostaining. RESULTS: The optimised synthesis of [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS resulted in straightforward protocols not requiring additional purification. [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS were synthesised with an average RCC of 98.4 % (n = 16) and 98.0 % (n = 13), respectively. Cell labelling efficiencies were 63.9 % (n = 35) and 70.2 % (n = 30), respectively. (89)Zr labelling neither significantly affected the cell viability (cell viability loss was in the range of 1–8 % compared to its corresponding non-labelled cells, P value > 0.05) nor the cells’ proliferation rate. The phenotype of human decidual stromal cells (hDSC) and phagocytic function of rat bone-marrow-derived macrophages (rMac) was somewhat affected by radiolabelling. CONCLUSIONS: Our study demonstrates that [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS are equally effective in cell labelling. However, [(89)Zr]Zr-oxine was superior to [(89)Zr]Zr-DFO-NCS with regard to long-term stability, cellular retention, minimal variation between cell types and cell labelling efficiency. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11307-021-01622-z. |
format | Online Article Text |
id | pubmed-8578071 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-85780712021-11-15 Optimisation of the Synthesis and Cell Labelling Conditions for [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications Friberger, Ida Jussing, Emma Han, Jinming Goos, Jeroen A. C. M. Siikanen, Jonathan Kaipe, Helen Lambert, Mélanie Harris, Robert A. Samén, Erik Carlsten, Mattias Holmin, Staffan Tran, Thuy A. Mol Imaging Biol Research Article BACKGROUND: There is a need to better characterise cell-based therapies in preclinical models to help facilitate their translation to humans. Long-term high-resolution tracking of the cells in vivo is often impossible due to unreliable methods. Radiolabelling of cells has the advantage of being able to reveal cellular kinetics in vivo over time. This study aimed to optimise the synthesis of the radiotracers [(89)Zr]Zr-oxine (8-hydroxyquinoline) and [(89)Zr]Zr-DFO-NCS (p-SCN-Bn-Deferoxamine) and to perform a direct comparison of the cell labelling efficiency using these radiotracers. PROCEDURES: Several parameters, such as buffers, pH, labelling time and temperature, were investigated to optimise the synthesis of [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS in order to reach a radiochemical conversion (RCC) of >95 % without purification. Radio-instant thin-layer chromatography (iTLC) and radio high-performance liquid chromatography (radio-HPLC) were used to determine the RCC. Cells were labelled with [(89)Zr]Zr-oxine or [(89)Zr]Zr-DFO-NCS. The cellular retention of (89)Zr and the labelling impact was determined by analysing the cellular functions, such as viability, proliferation, phagocytotic ability and phenotypic immunostaining. RESULTS: The optimised synthesis of [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS resulted in straightforward protocols not requiring additional purification. [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS were synthesised with an average RCC of 98.4 % (n = 16) and 98.0 % (n = 13), respectively. Cell labelling efficiencies were 63.9 % (n = 35) and 70.2 % (n = 30), respectively. (89)Zr labelling neither significantly affected the cell viability (cell viability loss was in the range of 1–8 % compared to its corresponding non-labelled cells, P value > 0.05) nor the cells’ proliferation rate. The phenotype of human decidual stromal cells (hDSC) and phagocytic function of rat bone-marrow-derived macrophages (rMac) was somewhat affected by radiolabelling. CONCLUSIONS: Our study demonstrates that [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS are equally effective in cell labelling. However, [(89)Zr]Zr-oxine was superior to [(89)Zr]Zr-DFO-NCS with regard to long-term stability, cellular retention, minimal variation between cell types and cell labelling efficiency. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11307-021-01622-z. Springer International Publishing 2021-07-06 2021 /pmc/articles/PMC8578071/ /pubmed/34231103 http://dx.doi.org/10.1007/s11307-021-01622-z Text en © The Author(s) 2021, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Friberger, Ida Jussing, Emma Han, Jinming Goos, Jeroen A. C. M. Siikanen, Jonathan Kaipe, Helen Lambert, Mélanie Harris, Robert A. Samén, Erik Carlsten, Mattias Holmin, Staffan Tran, Thuy A. Optimisation of the Synthesis and Cell Labelling Conditions for [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications |
title | Optimisation of the Synthesis and Cell Labelling Conditions for [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications |
title_full | Optimisation of the Synthesis and Cell Labelling Conditions for [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications |
title_fullStr | Optimisation of the Synthesis and Cell Labelling Conditions for [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications |
title_full_unstemmed | Optimisation of the Synthesis and Cell Labelling Conditions for [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications |
title_short | Optimisation of the Synthesis and Cell Labelling Conditions for [(89)Zr]Zr-oxine and [(89)Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications |
title_sort | optimisation of the synthesis and cell labelling conditions for [(89)zr]zr-oxine and [(89)zr]zr-dfo-ncs: a direct in vitro comparison in cell types with distinct therapeutic applications |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578071/ https://www.ncbi.nlm.nih.gov/pubmed/34231103 http://dx.doi.org/10.1007/s11307-021-01622-z |
work_keys_str_mv | AT fribergerida optimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT jussingemma optimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT hanjinming optimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT goosjeroenacm optimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT siikanenjonathan optimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT kaipehelen optimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT lambertmelanie optimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT harrisroberta optimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT samenerik optimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT carlstenmattias optimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT holminstaffan optimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications AT tranthuya optimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications |